Clinical studies of ABMT in non-Hodgkin's lymphoma.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Clinics in Haematology

• Publication date

  1986-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0308-2261(86)80008-XPMID 3516486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of non‐Hodgkin's lymphoma with chemoradiotherapy and allogenic marrow transplantation

  2007cited by this paper
• A pilot study of cyclical chemotherapy with high-dose methotrexate and CHOP (MTX-CHOP) in poor-prognosis non-Hodgkin's lymphoma (NHL)

  2004cited by this paper
• The Low-Grade Non-Hodgkin's Lymphomas: Challenges and Opportunities

  1985cited by this paper
• Development of specific surface receptors recognizing mannose-terminal glycoconjugates in cultured monocytes: a possible early marker for differentiation of monocyte into macrophage.

  1985cited by this paper
• Stage IV diffuse large-cell lymphoma: a long-term analysis.

  1985cited by this paper
• Classification of non‐Hodgkin's lymphomas. Reproducibility of major classification systems

  1985cited by this paper
• Immunologic heterogeneity of diffuse large cell lymphoma.

  1985cited by this paper
• Treatment of relapsed non-Hodgkin's lymphoma with a combination of hydroxyurea, ifosfamide, and etoposide.

  1985cited by this paper
• Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies.

  1985cited by this paper
• Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities.

  1985cited by this paper
• Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non‐Hodgkin's lymphoma

  1985cited by this paper
• Pediatric oncology group experience with modified LSA2‐L2 therapy in 107 children with non‐Hodgkin's lymphoma (Burkitt's lymphoma excluded)

  1985cited by this paper
• CHOP vs MEV for the treatment of non-Hodgkin's lymphoma of unfavourable histopathology: a randomized clinical trial.

  1985cited by this paper
• Long-term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen.

  1984cited by this paper
• Superintensive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's lymphoma.

  1984cited by this paper
• A clinicopathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens: comparison of the working formulation with the Rappaport and Kiel classifications.

  1984cited by this paper
• Biclonal B-cell lymphoma.

  1984cited by this paper
• Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas.

  1984cited by this paper
• Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma.

  1984cited by this paper
• A follow-up of a randomized study comparing two chemotherapy treatments for advanced diffuse histiocytic lymphoma.

  1984cited by this paper
• In Vitro Chemotherapy as a Prelude to Autologous Marrow Transplantation in Hematologic Malignancy

  1984cited by this paper
• Utilization of a human tumor cloning system to monitor for bone marrow involvement in children with non‐Hodgkin's lymphoma

  1984cited by this paper
• Non-Hodgkin's lymphoma: management strategies.

  1984cited by this paper
• How does bone-marrow transplantation cure leukaemia?

  1984cited by this paper
• Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.

  1984cited by this paper
• The role of autologous bone marrow transplantation in various malignancies.

  1984cited by this paper
• Role of massive chemotherapy and autologous bone-marrow transplantation in non-Hodgkin's malignant lymphoma.

  1984cited by this paper
• Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.

  1984cited by this paper
• Autologous bone marrow transplantation in the treatment of children and adolescents with advanced malignant tumors.

  1984cited by this paper
• Vindesine, carmustine, doxorubicin, and prednisone (EBAP) in recurrent lymphomas: a Southwest Oncology Group study.

  1984cited by this paper
• Marrow adipose cells and hemopoiesis: an interpretative review.

  1984cited by this paper
• NHL‐3 protocol six‐drug combination chemotherapy for non‐hodgkin's lymphoma

  1984cited by this paper
• The natural history of initially untreated low-grade non-Hodgkin's lymphomas.

  1984cited by this paper
• A multivariate analysis of factors affecting survival in patients with high-grade histology non-Hodgkin's lymphoma.

  1984cited by this paper
• Circulating monoclonal B lymphocytes in non-Hodgkin's lymphoma.

  1984cited by this paper
• Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.

  1983cited by this paper
• High-dose chemoradiotherapy and bone marrow transplantation in patients with refractory lymphoma.

  1983cited by this paper
• Derivation of lymphoma cell lines from microscopically normal bone marrow in patients with undifferentiated lymphomas: evidence of occult bone marrow involvement.

  1983cited by this paper
• Sequential cyclophosphamide‐prednisone and vincristine‐bleomycin (CPOB). An effective, schedule‐dependent treatment for advanced diffuse histiocytic lymphoma

  1983cited by this paper
• Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2).

  1983cited by this paper
• Patterns of relapse following chemotherapy in non-Hodgkin's lymphoma

  1983cited by this paper
• "Bad risk" non-Hodgkin lymphomas.

  1983cited by this paper
• Improved complete remission rates and survival for patients with large cell lymphoma treated with chemoimmunotherapy: A southwest oncology group study

  1983cited by this paper
• Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults. A pilot study.

  1983cited by this paper
• Combined modality therapy of advanced non-Hodgkin's lymphoma: an analysis of remission duration and survival in 95 patients.

  1983cited by this paper
• Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD).

  1983cited by this paper
• Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic type.

  1983cited by this paper
• Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.

  1983cited by this paper
• Kettering Award Lecture. The role of marrow transplantation in the eradication of malignant disease.

  1982cited by this paper
• IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy.

  1982cited by this paper
• High-dose AMSA and bone marrow rescue in patients with solid tumors.

  1982cited by this paper
• Kettering award lecture. The role of marrow transplantation in the eradication of malignant disease

  1982cited by this paper
• Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non‐Hodgkin's lymphomas. A report of 131 cases

  1982cited by this paper
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.

  1982cited by this paper
• Autologous bone marrow rescue in the treatment of advanced tumors of childhood

  1982cited by this paper
• Bone marrow and blood involvement by lymphoma in relationship to the lukes—collins classification

  1982cited by this paper
• Undifferentiated non‐Hodgkin'S lymphomas (Burkitt's and non‐Burkitt's types). The relevance of making this histologic distinction

  1982cited by this paper
• Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen.

  1982cited by this paper
• Phase I study of high-dose mitomycin with autologous bone marrow support.

  1982cited by this paper
• Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

  1982cited by this paper
• Studies with ifosfamide in patients with malignant lymphoma.

  1982cited by this paper
• Salvage chemotherapy for non-Hodgkin's lymphoma.

  1982cited by this paper
• Combined-modality therapy and autologous bone marrow transplantation in the treatment of advanced non-Hodgkin's lymphoma and solid tumor: the Kanazawa experience.

  1982cited by this paper
• Treatment of advanced diffuse histiocytic lymphoma: An analysis of prognostic variables

  1982cited by this paper
• Autologous nonfrozen bone marrow transplantation after intensive chemotherapy: a pilot study.

  1981cited by this paper
• The management of generalised grade 2 non-Hodgkin's lymphomas (Report no 18).

  1981cited by this paper
• Lymphoblastic lymphoma in adults: results of a pilot protocol.

  1981cited by this paper
• In vitro growth of lymphoma colonies from children with non‐hodgkin's lymphoma

  1981cited by this paper
• High-dose combined-modality therapy and autologous bone marrow transplantation in resistant cancer.

  1981cited by this paper
• Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disorders.

  1981cited by this paper
• Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma.

  1981cited by this paper
• Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twins.

  1981cited by this paper
• High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients.

  1981cited by this paper
• The chemotherapy of lymphoblastic lymphoma.

  1981cited by this paper
• Autologous bone marrow transplantation following chemotherapy and irradiation in dogs with spontaneous lymphomas.

  1980cited by this paper
• Requirements for the successful application of autologous bone marrow transplantation in the treatment of selected malignancies.

  1980cited by this paper
• High‐dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors

  1980cited by this paper
• Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.

  1980cited by this paper
• Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphoma.

  1980cited by this paper
• Dose: a critical factor in cancer chemotherapy.

  1980cited by this paper
• Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.

  1980cited by this paper
• Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

  1979cited by this paper
• Non‐Hodgkin's lymphoma in children. A progress report on the original patients treated with the LSA2‐L2 protocol

  1979cited by this paper
• Improved prognosis for patients with mediastinal lymphoblastic lymphoma.

  1979cited by this paper
• Prolonged disease-free survival in dogs with lymphoma after total-body irradiation and autologous marrow transplantation consolidation of combination-chemotherapy-induced remissions.

  1979cited by this paper
• Autologous bone marrow transplantation in the treatment of selected human malignancies: The Johns Hopkins Oncology Center Program.

  1979cited by this paper
• Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatment.

  1978cited by this paper
• Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapse

  1978cited by this paper
• Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma

  1978cited by this paper
• Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

  1978cited by this paper
• Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma.

  1978cited by this paper
• Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group.

  1977cited by this paper
• High dose methotrexate with citrovorum factor in adult resistant lymphoma

  1977cited by this paper
• Combination chemotherapy ("CHOP-Bleo") in advanced (non-Hodgkin) malignant lymphoma.

  1977cited by this paper
• Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.

  1977cited by this paper
• One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

  1977cited by this paper
• Curability of non-Hodgkin's lymphomas.

  1977cited by this paper
• Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).

  1977cited by this paper
• Curability of non-Hodgkin's lymphomas.

  1977cited by this paper
• Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.

  1976cited by this paper

• Cutaneous extra nodal lymphoma relapse: A case report and review of literature

  2018cites this paper
• Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse

  2015cites this paper
• Allogeneic and autologous bone marrow transplantation for acute leukemia and malignant lymphoma: current status.

  2006cites this paper
• Rituximab, Ara-C, Dexamethasone and Oxaliplatin Is Safe and Active in Heavily Pretreated Patients with Diffuse Large B-Cell Lymphoma

  2006cites this paper
• IMVP‐16 followed by high dose chemotherapy and autologous bone marrow transplantation as salvage treatment for malignant lymphoma

  2006cites this paper
• Haematological recovery following high-dose cyclophosphamide with autologous bone marrow transplantation

  2004cites this paper
• Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

  2004cites this paper
• Studies of the immune system of HOX11 transgenic mice for lymphoma immunotherapy

  1999cites this paper
• Autologous stem cell transplants in lymphomas.

  1996cites this paper
• Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

  1996cites this paper
• High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity.

  1995cites this paper
• Removal of carcinoma cells from contaminated bone marrow using the lipophilic cation rhodamine 123.

  1995cites this paper
• Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO.

  1994cites this paper
• Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease

  1994cites this paper
• NOPE for relapsed aggressive diffuse non-Hodgkin's lymphoma.

  1993cites this paper
• Autologous bone marrow transplantation.

  1993cites this paper
• Family issues.

  1993cites this paper
• High-dose chemotherapy: therapeutic potential in the age of growth factor support.

  1992cites this paper
• Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP.

  1992cites this paper
• Failure of IMVP‐16 as second‐line treatment for relapsed or refractory high grade non‐hodgkin's lymphoma

  1992cites this paper
• Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.

  1992cites this paper
• Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.

  1991cites this paper
• Supernatant cell counts from long-term bone marrow culture correlate with the speed of engraftment following autologous bone marrow transplantation.

  1991cites this paper
• Recent Advances in Bone Marrow Transplantation in Children

  1991cites this paper
• Non-Hodgkin's lymphoma : biologic classification and implication for therapy

  1991cites this paper
• Biologic agents and approaches in the management of patients with lymphoma. A critical appraisal.

  1991cites this paper
• Moving ahead in cancer research: who pays for patient supportive care for participation in experimental/investigational trials?

  1991cites this paper
• Comparison of high-dose therapy and autologous bone marrow transplantation for T-cell and B-cell non-Hodgkin's lymphomas.

  1990cites this paper
• Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.

  1990cites this paper
• [High dose chemotherapy and autologous bone marrow transplantation for advanced germ cell tumor].

  1990cites this paper
• The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation.

  1990cites this paper
• A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.

  1990cites this paper
• Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.

  1990cites this paper
• Phase 2 study of mitozantrone in combination with chlorambucil and prednisolone for relapsed and refractory non‐Hodgkins lymphoma

  1990cites this paper
• The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas.

  1990cites this paper
• The Management of Non-Hodgkin’s Lymphomas in Europe

  1990cites this paper
• High-dose thiotepa alone and in combination regimens with bone marrow support.

  1990cites this paper
• High-dose chemotherapy

  1990cites this paper
• Management of Non-Hodgkin’s Lymphomas in Adults in Scandinavia, the United Kingdom and the Netherlands: Conclusions of the Fourth Intercity Meeting, 1988

  1990cites this paper
• The Treatment of Progressive Non-Hodgkin's Lymphoma With Intensive Chemoradiotherapy and Autologous Marrow Transplantation

  1990cites this paper
• Very High Dose Therapy in Lymphomas and Solid Tumors

  1989cites this paper
• High‐dose chemotherapy with busulphan and cyclophosphamide and bone‐marrow transplantation for drug‐sensitive malignancies in adults: a preliminary report

  1989cites this paper
• [High-dosage chemo-radiotherapy with autologous bone marrow transfusion in malignant lymphoma: indications and personal experience].

  1989cites this paper
• Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function.

  1989cites this paper
• Management of non-Hodgkin lymphoma in adults in Scandinavia, United Kingdom, and The Netherlands. Report from the European School of Oncology intercity meeting at Huddinge Hospital, 3rd June, 1988.

  1989cites this paper
• Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

  1989cites this paper
• Autologous bone-marrow transplantation in non-Hodgkin's lymphomas.

  1989cites this paper
• Autologous bone marrow transplantation in children.

  1988cites this paper
• Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma.

  1988cites this paper
• Cyclophosphamide and thiotepa with autologous bone marrow transplantation in patients with solid tumors.

  1988cites this paper
• Complement-mediated cytolysis: quantification of B cell surface antigen molecules and role of cell cycle.

  1988cites this paper
• [The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].

  1988cites this paper
• Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

  1987cites this paper
• Monoclonal antibodies: their use in bone marrow transplantation.

  1987cites this paper
• The role of autologous bone marrow transplantation in the treatment of malignant disease.

  1987cites this paper
• Bone marrow transplantation.

  1987cites this paper
• Autologous bone marrow transplantation for patients with acute myeloid leukaemia and acute lymphoblastic leukaemia--a comparison.

  1987cites this paper
• Bone marrow transplantation.

  1987cites this paper
• Intensive chemoradiotherapy and autologous bone marrow transplantation for resistant lymphoma.

  1987cites this paper
• Allogeneic and autologous bone marrow transplantation for acute leukemia and malignant lymphoma: Current status

  1987cites this paper
• Marrow transplantation for malignant lymphoma.

  1987cites this paper
• Non‐hodgkin's lymphoma of unfavourable histology: A multivariate analysis of factors predicting the response to chop

  1987cites this paper
• Bone marrow transplantation for malignant lymphoma.

  1987cites this paper
• Management of multiple myeloma.

  1987cites this paper
• Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.

  1987cites this paper
• Advanced lymphoma and CHOP chemotherapy.

  1986cites this paper
• [Strategies in the treatment of non-Hodgkin's lymphomas].

  1986cites this paper
• Blood and blood products

  1986cites this paper